| UniProt ID | HAP28_HUMAN | |
|---|---|---|
| UniProt AC | Q13442 | |
| Protein Name | 28 kDa heat- and acid-stable phosphoprotein | |
| Gene Name | PDAP1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 181 | |
| Subcellular Localization | ||
| Protein Description | Enhances PDGFA-stimulated cell growth in fibroblasts, but inhibits the mitogenic effect of PDGFB.. | |
| Protein Sequence | MPKGGRKGGHKGRARQYTSPEEIDAQLQAEKQKAREEEEQKEGGDGAAGDPKKEKKSLDSDESEDEEDDYQQKRKGVEGLIDIENPNRVAQTTKKVTQLDLDGPKELSRREREEIEKQKAKERYMKMHLAGKTEQAKADLARLAIIRKQREEAARKKEEERKAKDDATLSGKRMQSLSLNK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 7 | Methylation | -MPKGGRKGGHKGRA -CCCCCCCCCCCCCC | 72.95 | 116252659 | |
| 17 | Phosphorylation | HKGRARQYTSPEEID CCCCCCCCCCHHHHH | 12.02 | 21945579 | |
| 18 | Phosphorylation | KGRARQYTSPEEIDA CCCCCCCCCHHHHHH | 29.48 | 25159151 | |
| 19 | Phosphorylation | GRARQYTSPEEIDAQ CCCCCCCCHHHHHHH | 25.94 | 25159151 | |
| 31 | Ubiquitination | DAQLQAEKQKAREEE HHHHHHHHHHHHHHH | 61.18 | 21906983 | |
| 31 | Acetylation | DAQLQAEKQKAREEE HHHHHHHHHHHHHHH | 61.18 | 26051181 | |
| 33 | Ubiquitination | QLQAEKQKAREEEEQ HHHHHHHHHHHHHHH | 61.55 | 22817900 | |
| 52 | Acetylation | DGAAGDPKKEKKSLD CCCCCCCHHHHCCCC | 77.60 | 12429493 | |
| 52 | Sumoylation | DGAAGDPKKEKKSLD CCCCCCCHHHHCCCC | 77.60 | 28112733 | |
| 53 | Acetylation | GAAGDPKKEKKSLDS CCCCCCHHHHCCCCC | 78.96 | 12649937 | |
| 55 | Acetylation | AGDPKKEKKSLDSDE CCCCHHHHCCCCCCC | 57.45 | 12649949 | |
| 57 | Phosphorylation | DPKKEKKSLDSDESE CCHHHHCCCCCCCCC | 48.77 | 26846344 | |
| 60 | Phosphorylation | KEKKSLDSDESEDEE HHHCCCCCCCCCCCH | 48.87 | 22167270 | |
| 63 | Phosphorylation | KSLDSDESEDEEDDY CCCCCCCCCCCHHHH | 56.17 | 22167270 | |
| 70 | Phosphorylation | SEDEEDDYQQKRKGV CCCCHHHHHHHHHCC | 25.76 | 23927012 | |
| 75 | Ubiquitination | DDYQQKRKGVEGLID HHHHHHHHCCCCCCC | 74.48 | 24816145 | |
| 75 | Acetylation | DDYQQKRKGVEGLID HHHHHHHHCCCCCCC | 74.48 | 26051181 | |
| 95 | Ubiquitination | RVAQTTKKVTQLDLD HHHHHCCCEEECCCC | 48.71 | 24816145 | |
| 97 | Phosphorylation | AQTTKKVTQLDLDGP HHHCCCEEECCCCCH | 32.09 | 27251275 | |
| 105 | Acetylation | QLDLDGPKELSRRER ECCCCCHHHHCHHHH | 76.46 | 23236377 | |
| 105 | Ubiquitination | QLDLDGPKELSRRER ECCCCCHHHHCHHHH | 76.46 | 22817900 | |
| 117 | Ubiquitination | REREEIEKQKAKERY HHHHHHHHHHHHHHH | 63.86 | - | |
| 119 | Ubiquitination | REEIEKQKAKERYMK HHHHHHHHHHHHHHH | 72.92 | 24816145 | |
| 126 | Methylation | KAKERYMKMHLAGKT HHHHHHHHHHHCCCH | 17.77 | 24129315 | |
| 126 | 2-Hydroxyisobutyrylation | KAKERYMKMHLAGKT HHHHHHHHHHHCCCH | 17.77 | - | |
| 126 | Acetylation | KAKERYMKMHLAGKT HHHHHHHHHHHCCCH | 17.77 | 25953088 | |
| 126 | Ubiquitination | KAKERYMKMHLAGKT HHHHHHHHHHHCCCH | 17.77 | 29967540 | |
| 132 | Ubiquitination | MKMHLAGKTEQAKAD HHHHHCCCHHHHHHH | 43.19 | 19608861 | |
| 132 | 2-Hydroxyisobutyrylation | MKMHLAGKTEQAKAD HHHHHCCCHHHHHHH | 43.19 | - | |
| 132 | Acetylation | MKMHLAGKTEQAKAD HHHHHCCCHHHHHHH | 43.19 | 19608861 | |
| 133 | Phosphorylation | KMHLAGKTEQAKADL HHHHCCCHHHHHHHH | 32.20 | 26437602 | |
| 137 | Ubiquitination | AGKTEQAKADLARLA CCCHHHHHHHHHHHH | 41.97 | 24816145 | |
| 137 | Acetylation | AGKTEQAKADLARLA CCCHHHHHHHHHHHH | 41.97 | 26822725 | |
| 164 | Methylation | KEEERKAKDDATLSG HHHHHHHHHHCCCCC | 60.21 | 72620173 | |
| 164 | Acetylation | KEEERKAKDDATLSG HHHHHHHHHHCCCCC | 60.21 | - | |
| 164 | Ubiquitination | KEEERKAKDDATLSG HHHHHHHHHHCCCCC | 60.21 | 24816145 | |
| 168 | Phosphorylation | RKAKDDATLSGKRMQ HHHHHHCCCCCHHHH | 28.57 | 23312004 | |
| 170 | Phosphorylation | AKDDATLSGKRMQSL HHHHCCCCCHHHHHH | 37.60 | 21815630 | |
| 172 | Ubiquitination | DDATLSGKRMQSLSL HHCCCCCHHHHHHCC | 41.12 | 33845483 | |
| 172 | Acetylation | DDATLSGKRMQSLSL HHCCCCCHHHHHHCC | 41.12 | 23954790 | |
| 172 | 2-Hydroxyisobutyrylation | DDATLSGKRMQSLSL HHCCCCCHHHHHHCC | 41.12 | - | |
| 174 | Sulfoxidation | ATLSGKRMQSLSLNK CCCCCHHHHHHCCCC | 3.46 | 21406390 | |
| 176 | Phosphorylation | LSGKRMQSLSLNK-- CCCHHHHHHCCCC-- | 15.58 | 29255136 | |
| 178 | Phosphorylation | GKRMQSLSLNK---- CHHHHHHCCCC---- | 34.83 | 29255136 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of HAP28_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HAP28_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HAP28_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PDGFA_HUMAN | PDGFA | physical | 8780057 | |
| PDGFB_HUMAN | PDGFB | physical | 8780057 | |
| A4_HUMAN | APP | physical | 21832049 | |
| RBM8A_HUMAN | RBM8A | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-132, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57; SER-60; SER-63 ANDSER-176, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57; SER-60 AND SER-63,AND MASS SPECTROMETRY. | |
| "Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57; SER-60 AND SER-63,AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-57; SER-60;SER-63 AND SER-176, AND MASS SPECTROMETRY. | |
| "Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60 AND SER-63, AND MASSSPECTROMETRY. | |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63, AND MASSSPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60; SER-63 AND TYR-70,AND MASS SPECTROMETRY. | |
| "Toward a global characterization of the phosphoproteome in prostatecancer cells: identification of phosphoproteins in the LNCaP cellline."; Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.; Electrophoresis 28:2027-2034(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63, AND MASSSPECTROMETRY. | |
| "Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60 AND SER-63, AND MASSSPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60 AND SER-63, AND MASSSPECTROMETRY. | |
| "Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-17, AND MASSSPECTROMETRY. | |